This article is part of the network’s archive of useful research information. This article is closed to new comments due to inactivity. We welcome new content which can be done by submitting an article for review or take part in discussions in an open topic or submit a blog post to take your discussions online.
ARTICLE ABSTRACT
A colleague and I recently reported on the first 2 years of the European Medicines Agency’s (EMA’s) November 2010 freedom of information policy on access to documents. The policy made a wide range of regulatory documents potentially accessible to anyone who asked for them, including clinical study reports. As of November 19, 2012, the EMA had released approximately 1.66 million pages of clinical trial data and other documents in response to 457 requests.
To read full article: https://www.ncbi.nlm.nih.gov/pubmed/23959623